Ethanol modulate central and peripheral immune responses via HMGB1, IL-1Beta, and other Immune Signaling Molecules
乙醇通过 HMGB1、IL-1Beta 和其他免疫信号分子调节中枢和外周免疫反应
基本信息
- 批准号:10238811
- 负责人:
- 金额:$ 12.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectAgonistAlcohol abuseAlcohol consumptionAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholismAlcoholsAutophagocytosisBasic ScienceBiological AssayBody SurfaceBrainBurn injuryCell CommunicationCell Culture SystemCellsCessation of lifeChronicClinicalClinical ResearchCo-ImmunoprecipitationsCompanionsCritical IllnessDataDevelopmentDiseaseDoctor of PhilosophyDoseEnsureEnzymesEthanolFRAP1 geneFlow CytometryFoundationsGlycyrrhizic AcidGoalsHMGB1 geneHourHumanImmuneImmune System DiseasesImmune responseImmune signalingImmune systemIn VitroInflammationInflammatoryInflammatory Response PathwayInjectionsInnate Immune ResponseInnate Immune SystemInterleukin-1Interleukin-1 betaIntestinal permeabilityKineretLabelLaboratoriesLeadLearningLinkLipidsLiverLungMass Spectrum AnalysisMeasuresMediatingMentorsMentorshipMicrogliaModelingMusNatural ImmunityNeurogliaNeuronsOrganOutcomePTEN genePathologyPathway interactionsPatientsPeripheralPharmacotherapyPlasmaPneumoniaPoly I-CProteinsRecording of previous eventsRecoveryResearchResearch PersonnelRoleSecondary toSepsisSeverity of illnessSignal PathwaySignal TransductionSignaling MoleculeSirolimusSliceSpleenStomachTLR3 geneTLR4 geneTechniquesTestingTimeTissuesViralWestern BlottingWorkalcohol effectalcohol exposurealcohol use disordercareercareer developmentcell typecytokineexperimental studyfluorescence imagingimmune activationimmunocytochemistryin vivoinhibitor/antagonistlaboratory experiencemortalityneuroinflammationnovelnovel therapeuticspreventable deathproblem drinkerprotective effectresearch and developmentresponsesystemic inflammatory responsetranslational scientistuptakevesicular releasewortmannin
项目摘要
Project Summary/Abstract
Alcohol use disorders are third leading cause of preventable death, accounting for
approximately 90,000 preventable deaths each year (Danaei et al 2009). Nearly 50%
deaths are secondary to diseases that are associated with inflammation and aberrant
immune activation such as sepsis and alcoholic liver disease (Mokdad et al 2000).
Recent discoveries find that alcohol activates the innate immune system in both the
CNS and periphery. Thus, understanding the effects of alcohol on the immune system
is critical to form a foundation of discovery leading to the understanding of both the
pathology of alcoholism and numerous alcohol-associated diseases. We have found
recently that alcohol activates the innate immune system through the ‘master regulator’
of innate immunity, HMGB1. In this proposal we aim to investigate the effects of alcohol
on central and peripheral immune activation through HMGB1 and its companion
cytokine IL-. Using in vitro cell culture systems (Aim 1), in vivo experiments (Aim 2-3)
and assessments in human alcoholics, burn patients and alcoholic hepatitis patients
(Aim 4), we hope to gain an understanding of the immune effects of alcohol throughout
the body. I will gain new laboratory experience with real time-PCR, enzyme-linked
immunosorbant assays, co-immunoprecipitation, western blotting, intracerebral AAV5
viral injections, mass spectrometry, immunocytochemistry, and live fluorescent imaging.
We also investigate a novel mechanism of cell-cell communication in this pathology,
alcohol-induced release of pro-inflammatory microparticles. Further, we investigate the
role of the PTEN/PI3K/Akt/mTOR pathway in the immune effects of alcohol, and study
inhibitors of this pathway which may be novel therapeutic options. Our preliminary data
strongly suggest that alcohol causes central and peripheral HMGB1 and IL-1 release
in microparticles through a PTEN/PI3K/Akt/mTOR linked mechanism. This project also
incorporates substantial career development with career and research mentoring from
top tier researchers and clinicians, the learning of new experimental techniques, and
course work to enhance clinical/translational expertise. Co-mentors Fulton T. Crews,
PhD and Bruce Cairns MD provide a depth of basic science, clinical research, and
career development mentorship that will help ensure the successful transition of the
candidate to being a top independent translational researcher.
项目摘要/摘要
饮酒障碍是可预防死亡的第三主要原因
每年约有90,000例可预防的死亡(Danaei等,2009)。近50%
死亡是与感染和异常相关的疾病继发的
免疫激活,例如败血症和酒精性肝病(Mokdad等,2000)。
最近发现,酒精激活了同时的先天免疫系统
中枢神经系统和外围。这是了解酒精对免疫系统的影响
构成发现的基础至关重要
酒精中毒的病理和许多与酒精相关的疾病。我们找到了
最近,酒精通过“主调节器”激活先天免疫系统
先天免疫,HMGB1。在此提案中,我们旨在调查酒精的影响
通过HMGB1及其伴侣在中央和周围免疫激活上
细胞因子IL-。使用体外细胞培养系统(AIM 1),体内实验(AIM 2-3)
以及人类酗酒者,烧伤患者和酒精性肝炎患者的评估
(AIM 4),我们希望能够了解整个酒精的免疫作用
身体。我将通过实时PCR,酶联的新实验室经验
免疫吸附测定,共免疫沉淀,蛋白质印迹,脑内AAV5
病毒注射,质谱,免疫细胞化学和活荧光成像。
我们还研究了这种病理学中细胞 - 细胞通信的新机制,
酒精诱导的促炎性微粒的释放。此外,我们研究了
pten/pi3k/akt/mtor途径在酒精的免疫学影响中的作用,并研究
这种途径的抑制剂可能是新的治疗选择。我们的初步数据
强烈建议酒精会导致中央和周围HMGB1和IL-1释放
通过PTEN/PI3K/AKT/MTOR链接机制在微粒中。这个项目也是如此
将实质性的职业发展与职业和研究的心理联系在一起
顶级研究人员和临床医生,新实验技术的学习以及
课程工作以增强临床/翻译专业知识。联合官员Fulton T. Crews,
博士和布鲁斯·凯恩斯(Bruce Cairns)医学博士提供了基础科学,临床研究和
职业发展指导将有助于确保成功过渡
候选人是一名最高独立的翻译研究人员。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chronic Ethanol Causes Persistent Increases in Alzheimer's Tau Pathology in Female 3xTg-AD Mice: A Potential Role for Lysosomal Impairment.
- DOI:10.3389/fnbeh.2022.886634
- 发表时间:2022
- 期刊:
- 影响因子:3
- 作者:
- 通讯作者:
Microglial depletion and repopulation: a new era of regenerative medicine?
- DOI:10.4103/1673-5374.300439
- 发表时间:2021-06
- 期刊:
- 影响因子:6.1
- 作者:Barnett AM;Crews FT;Coleman LG
- 通讯作者:Coleman LG
Ethanol Induces Secretion of Proinflammatory Extracellular Vesicles That Inhibit Adult Hippocampal Neurogenesis Through G9a/GLP-Epigenetic Signaling.
- DOI:10.3389/fimmu.2022.866073
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
Adolescent Binge Alcohol Enhances Early Alzheimer's Disease Pathology in Adulthood Through Proinflammatory Neuroimmune Activation.
- DOI:10.3389/fphar.2022.884170
- 发表时间:2022
- 期刊:
- 影响因子:5.6
- 作者:Barnett, Alexandra;David, Emeraghi;Rohlman, Aaron;Nikolova, Viktoriya D.;Moy, Sheryl S.;Vetreno, Ryan P.;Coleman, Leon G., Jr.
- 通讯作者:Coleman, Leon G., Jr.
Extracellular microvesicles promote microglia-mediated pro-inflammatory responses to ethanol.
- DOI:10.1002/jnr.24813
- 发表时间:2021-08
- 期刊:
- 影响因子:4.2
- 作者:Crews FT;Zou J;Coleman LG Jr
- 通讯作者:Coleman LG Jr
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leon Garland Coleman其他文献
Leon Garland Coleman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leon Garland Coleman', 18)}}的其他基金
Scientific Mentoring and Research Experiences Core
科学指导和研究经验核心
- 批准号:
10541712 - 财政年份:2022
- 资助金额:
$ 12.81万 - 项目类别:
Scientific Mentoring and Research Experiences Core
科学指导和研究经验核心
- 批准号:
10705747 - 财政年份:2022
- 资助金额:
$ 12.81万 - 项目类别:
Ethanol Inhibition of anti-PD-1 Immunotherapy via T-cell Dysfunction and Intestinal Dysbiosis
乙醇通过 T 细胞功能障碍和肠道菌群失调抑制抗 PD-1 免疫治疗
- 批准号:
10218700 - 财政年份:2021
- 资助金额:
$ 12.81万 - 项目类别:
Ethanol Inhibition of anti-PD-1 Immunotherapy via T-cell Dysfunction and Intestinal Dysbiosis
乙醇通过 T 细胞功能障碍和肠道菌群失调抑制抗 PD-1 免疫治疗
- 批准号:
10403618 - 财政年份:2021
- 资助金额:
$ 12.81万 - 项目类别:
Ethanol modulate central and peripheral immune responses via HMGB1, IL-1Beta, and other Immune Signaling Molecules
乙醇通过 HMGB1、IL-1Beta 和其他免疫信号分子调节中枢和外周免疫反应
- 批准号:
9314186 - 财政年份:2017
- 资助金额:
$ 12.81万 - 项目类别:
Ethanol modulate central and peripheral immune responses via HMGB1, IL-1Beta, and other Immune Signaling Molecules
乙醇通过 HMGB1、IL-1Beta 和其他免疫信号分子调节中枢和外周免疫反应
- 批准号:
10004214 - 财政年份:2017
- 资助金额:
$ 12.81万 - 项目类别:
Ethanol modulate central and peripheral immune responses via HMGB1, IL-1Beta, and other Immune Signaling Molecules
乙醇通过 HMGB1、IL-1Beta 和其他免疫信号分子调节中枢和外周免疫反应
- 批准号:
9757591 - 财政年份:2017
- 资助金额:
$ 12.81万 - 项目类别:
相似国自然基金
SSRP1/Sp-1转录调控的MFGE8通过SIRT6影响铁死亡在脓毒症急性肾损伤中的机制研究
- 批准号:82302418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人群mtDNA空间异质性对急性高原反应发病的影响机制研究
- 批准号:42377466
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
- 批准号:82360025
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
高甘油三酯通过TLR4/caspase-8影响急性胰腺炎CD4+T细胞程序性死亡的机制研究
- 批准号:82360135
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 12.81万 - 项目类别:
A rigorous test of dual process model predictions for problematic alcohol involvement
对有问题的酒精参与的双过程模型预测的严格测试
- 批准号:
10679252 - 财政年份:2023
- 资助金额:
$ 12.81万 - 项目类别:
Shifting paradigms to emerging toxins in freshwater cyanobacterial blooms
淡水蓝藻水华中新出现的毒素的范式转变
- 批准号:
10912318 - 财政年份:2023
- 资助金额:
$ 12.81万 - 项目类别:
Detecting Adolescent Suicidality Biometric Signals and Dynamic Variability with Wearable Technology
利用可穿戴技术检测青少年自杀生物特征信号和动态变异性
- 批准号:
10731651 - 财政年份:2023
- 资助金额:
$ 12.81万 - 项目类别:
CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
- 批准号:
10701136 - 财政年份:2023
- 资助金额:
$ 12.81万 - 项目类别: